date:Aug 07, 2012
en asked by the Medicines and Healthcare products Regulatory Agency (MHRA) to advise whether a certain product containing DMAA should be classed as an unlicensed medicine and therefore subject to medicine controls. This advice may also have implications for the status of other DMAA-containing supplements.